Erik J. Ostrowski serves as the Senior Vice President, Chief Financial Officer, Chief Business Officer, and Treasurer at Akebia Therapeutics Inc., a biopharmaceutical company focused on developing and commercializing innovative treatments for kidney disease. In his multifaceted role, Ostrowski is responsible for overseeing the company's financial operations, strategic business development, and treasury functions. His leadership is crucial in driving Akebia's growth and ensuring its financial health as it navigates the competitive landscape of the biopharmaceutical industry. Prior to joining Akebia, Ostrowski amassed a wealth of experience in the life sciences sector. He held several senior financial positions at prominent companies, including serving as the Chief Financial Officer at Valeritas, Inc., where he played a pivotal role in the company's financial strategy and growth initiatives. Ostrowski's career also includes significant tenures at major corporations such as Johnson & Johnson and Pfizer, where he honed his skills in financial management and strategic planning. His extensive background has equipped him with the expertise needed to guide Akebia through complex financial and business challenges. Ostrowski's achievements in his current role at Akebia are notable. He has been instrumental in securing funding and forging strategic partnerships that have propelled the company's research and development efforts forward. Under his financial stewardship, Akebia has successfully navigated the intricacies of the market, maintaining a strong balance sheet and positioning the company for future success. His strategic vision and dedication to Akebia's mission of improving the lives of patients with kidney disease make him an invaluable asset to the organization.